Sonographic Measurement of Mesenteric Fat Predicts Presence of Fatty Liver among Subjects with Polycystic Ovary Syndrome

Autor: C. W. K. Lam, Juliana C.N. Chan, Chun-Chung Chow, Michael Ho-Ming Chan, Wing-Yee So, Peter C.Y. Tong, Po Mui Lam, Lai Ping Cheung, Winnie C.W. Chu, Kin Hung Liu, C. S. Ho, Ronald C.W. Ma, G. T. C. Ko, Wing Hung Tam
Rok vydání: 2011
Předmět:
Adult
medicine.medical_specialty
Endocrinology
Diabetes and Metabolism

Clinical Biochemistry
Subcutaneous Fat
Adipose tissue
Biochemistry
Young Adult
Endocrinology
Sex hormone-binding globulin
Waist–hip ratio
Liver Function Tests
Predictive Value of Tests
Risk Factors
Internal medicine
polycyclic compounds
Humans
Medicine
Mesentery
reproductive and urinary physiology
Ultrasonography
Anthropometry
biology
medicine.diagnostic_test
Waist-Hip Ratio
business.industry
fungi
Biochemistry (medical)
Fatty liver
Hyperandrogenism
food and beverages
Glucose Tolerance Test
medicine.disease
Lipids
Polycystic ovary
Blood Cell Count
Fatty Liver
medicine.anatomical_structure
Adipose Tissue
biology.protein
Female
Waist Circumference
business
Liver function tests
Blood Chemical Analysis
hormones
hormone substitutes
and hormone antagonists

Polycystic Ovary Syndrome
Zdroj: The Journal of Clinical Endocrinology & Metabolism. 96:799-807
ISSN: 1945-7197
0021-972X
DOI: 10.1210/jc.2010-1608
Popis: Visceral fat is believed to be important in the pathogenesis of metabolic syndrome and fatty liver. In this study, we examined the relationship between mesenteric fat thickness and other sonographic indices of adiposity and the presence of fatty liver among subjects with polycystic ovary syndrome (PCOS).A total of 117 Chinese subjects with PCOS were evaluated (mean age, 28.6 ± 6.5 yr; mean body mass index, 24.3 ± 5.3 kg/m(2)). Anthropometric measurements and metabolic risk profile, including a standard oral glucose tolerance test, were assessed in all subjects. All subjects underwent an ultrasound examination for measurement of thickness of mesenteric, preperitoneal, and sc fat as well as evaluation for fatty liver.Forty-six (39.3%) of the subjects had fatty liver. PCOS subjects with fatty liver had higher body mass index, waist circumference, waist-hip ratio, and systolic blood pressure; a more unfavorable lipid profile with higher triglyceride; lower high-density lipoprotein cholesterol; higher fasting glucose and insulin; higher 2-h glucose during oral glucose tolerance test; lower SHBG; and higher alanine aminotransferase. Subjects with fatty liver had increased thickness of preperitoneal, mesenteric, and sc fat, as well as increased carotid intima-media thickness. Abdominal fat thickness showed moderate correlation to alanine aminotransferase as well as fasting insulin. On multivariate logistic regression, fasting insulin and mesenteric fat thickness were identified as independent predictors of fatty liver among subjects with PCOS.Fatty liver is present in a significant proportion of Chinese patients with PCOS. Sonographic measurement of mesenteric fat is an independent determinant of fatty liver among subjects with PCOS and identifies subjects at increased cardiovascular risk.
Databáze: OpenAIRE